Innovent's Mazdutide Approved in China for Glycemic Control in Type 2 Diabetes

Innovent Biologics announced that China's NMPA has approved mazdutide, a first-in-class dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor a...